Cerebral Spinal Fluid Management Market Worth $1.4 Billion By 2022

The global cerebral spinal fluid (CSF) management market size is anticipated to reach USD 1.4 billion by 2022, according to a new report by Grand View Research, Inc. Constant evaluation of various techniques by neurosurgeons for improvement of hydrocephalus management is expected to drive growth in this market. Moreover, shunt manufacturers are engaged in the investment for the development of novel and improved shunts in order to tackle the pitfalls associated with the existing designs.

A significant increase in the geriatric population across the globe as well as a rise in the incidence of chronic CNS associated disorders such as stroke can be attributed to projected growth. Furthermore, grants for research in neuromodulation therapies in order to develop different products for the prognosis of various nervous system associated disorders are expected to boost development.

 To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/csf-management-market-analysis-market

Further Key Findings from the Study Suggest:

• CSF management devices are expected to witness extensive competition owing to the presence of several market players operating in this segment. Rise in the number of CSF associated disorders such as trauma and stroke are anticipated to boost demand for these products in the coming years.

• Cerebral spinal fluid management shunts captured the largest market share in terms of revenue generation in 2014.

• These devices are most commonly used for supplementing and replacing lost drainage capacity in case of CSF leak management.

• CSF drainage is anticipated to witness lucrative growth over the forecast period.

• This growth can be attributed to ongoing development for enhancing the overall safety of guidance-based systems and anti-biotic impregnated catheters incorporation.

• In 2014, North America accounted for the largest share with respect to revenue generation.

• Factors contributive for the share include a continuous increase in the number of Americans affected by Hydrocephalus coupled with ongoing research in neuroscience.

• Asia Pacific is expected to propel with the fastest CAGR owing to constantly improving the healthcare system in the region.

• Moreover, the economic progress of Asia Pacific countries such as China has led to a significant transformation of neurology and neurologic practices in the country. This is one of the key drivers to propel progress in this region in the coming years.

• Some of the key players operating in the cerebrospinal fluid management market include Johnson & Johnson Services, Inc; B.Braun Melsungen AG; Magstim; Elekta AB; Medtronic, Inc.; Integra LifeSciences Corporation; Phoenix Biomedical Corp.; Sophysa; Spiegelberg GmbH & Co. KG; and Beckersmith Medical, Inc.

• These players are engaged in the development of novel platforms for CSF management.

Grand View Research has segmented the global cerebral spinal fluid management market on the basis of products and region:

CSF Management Product Outlook (Revenue, USD Million, 2012 - 2022)

• CSF shunts

• CSF drainage

CSF Management Regional Outlook (Revenue, USD Million, 2012 - 2022)

• North America

• Europe

• Asia Pacific

• RoW